Price and states served both move. Read them off the seller's own site before you enroll.How our reviews work →

GOAL.MD vs Healthicare

Healthicare costs $5 less a month, and both sell semaglutide and tirzepatide.

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

By Ruth Calder · Enforcement Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed
GOAL.MD logo

GOAL.MD

7.8
★★★★☆3.9/5

Best for: starting below a standard dose, with microdose tiers

Visit GOAL.MD →
VS
Healthicare logo

Healthicare

7.4
★★★★☆3.7/5

Best for: moving between compounded and brand without changing seller

Visit Healthicare →

If you are choosing between GOAL.MD and Healthicare, the first difference is cost: Healthicare is $5 a month cheaper at the entry price. Both prescribe semaglutide and tirzepatide, so moving from one to the other would not change your drug. GOAL.MD leads our six-part score, 7.8 to 7.4.

GOAL.MD vs Healthicare price

Healthicare is the cheaper way in: $174 a month against $179 a month at GOAL.MD. That is $5 less each month (3% lower), or about $60 over a year of treatment.

Drug by drug: Semaglutide is cheaper at Healthicare ($174 a month vs $179 a month); tirzepatide is cheaper at GOAL.MD ($249 a month vs $264 a month).

Medications and formats

Both sell semaglutide and tirzepatide.

On format, GOAL.MD prices compounded injections and brand-name pens, while Healthicare prices compounded injections, an oral option and brand-name pens.

Where each one treats patients

GOAL.MD lists 50 states, and Healthicare does not publish where it ships.

Pricing

GOAL.MD

Personalized (compounded, all doses)Compounded
$179/mo
semaglutide
Micro-Dose (compounded)Compounded
$197/mo
semaglutide
Oral pillBrand-name
$244/mo
semaglutide
0.25-0.5 mg penBrand-name
$294/mo
ozempic
1 mg penBrand-name
$444/mo
ozempic
2 mg penBrand-name
$594/mo
ozempic
Pen (starter)Brand-name
$294/mo
wegovy
Vial / KwikPenBrand-name
$394/mo
zepbound
StartingCompounded
$249/mo
tirzepatide

Personalized (compounded) tirzepatide from $249/mo new-patient first month; brand Zepbound from $394/mo

Healthicare

Compounded semaglutide (billed monthly)Compounded
$174/mo
semaglutide

$174/mo billed monthly; $147.90/mo on the 3-month plan ($443.70 billed every 3 months)

Compounded tirzepatide (billed monthly)Compounded
$264/mo
tirzepatide

$264/mo billed monthly; $224.40/mo on the 3-month plan ($673.20 billed every 3 months)

Semaglutide Oral Dropsoral
$250$150/mo
Save 40% right now
semaglutide

$149.99 first month ($100 off), $249.99/mo after

Brand Ozempic / Wegovy / Mounjaro / ZepboundBrand-name
$1300$1200/mo
Save 8% right now
semaglutide

From $1,299.99/mo; first month From $1,199.99 ($100 off)

What each price covers

Both prices cover the clinician visit, the medication itself, shipping and coaching.

GOAL.MD is silent on lab work.

Healthicare is silent on lab work.

GOAL.MD

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Healthicare

Covered by the monthly price

Medication

In the price

Clinician visits

In the price

Shipping

In the price

Lab work

Not stated

Coaching

In the price

Where each one scores higher

Overall, GOAL.MD scores 7.8 and Healthicare 7.4 out of 10.

GOAL.MD is stronger on accessibility (10.0 vs 5.0).

Value, effectiveness, user experience, trust & safety and support are within half a point.

How we score

GOAL.MD

7.8/10

Overall

Healthicare

7.4/10

Value25%

5.2A
vs
B
5.4

Effectiveness25%

10.0A
vs
B
10.0

User Experience15%

8.0A
vs
B
8.0

Trust & Safety15%

6.5A
vs
B
6.5

Accessibility10%

10.0A
vs
B
5.0

Support10%

8.5A
vs
B
8.5

FDA warning letters

Neither GOAL.MD nor Healthicare has an FDA warning letter on record with us.

Features & Coverage

FeatureGOAL.MDHealthicare
Starting Price$179/mo✓$174/mo
Features8 features8 features
States Available50Not disclosed
Compounded✓ Yes✓ Yes
Brand Name✓ Yes✓ Yes
FSA/HSA Accepted——
FDA Warning LettersNoneNone

About GOAL.MD

GOAL.MD is a St. Louis-based telehealth platform. Compounded semaglutide starts at $179/mo, brand Ozempic and Wegovy from $294/mo, and Zepbound from $394/mo, with brand pen pricing published by dose tier and offered as a bridge to the brand drugs. Renewals are manual with no auto-billing, and a nutrition coach is included free.

Read our full GOAL.MD review →

About Healthicare

Two names Healthicare puts in public that most of this segment keeps quiet: Beluga Health, its clinical partner, and Jungle Jim's Pharmacy of Fairfield, OH, which dispenses. Coverage on this GLP-1 telehealth platform reaches 44 states. Compounded semaglutide opens at $147.90/mo, compounded tirzepatide at $224.40/mo. One account also reaches the full brand menu, Zepbound, Mounjaro, Wegovy, and Ozempic.

Read our full Healthicare review →

Pros & Cons

GOAL.MD

What we like

  • Semaglutide costs $179 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $394 a month, 68% below the $1249 median for brand-name tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • Serves all 50 states
  • We found no FDA warning letters issued to GOAL.MD

Watch-outs

  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Healthicare

What we like

  • Semaglutide costs $174 a month, close to the $184 median for compounded semaglutide across the sellers we compare
  • Tirzepatide costs $264 a month, close to the $250 median for compounded tirzepatide across the sellers we compare
  • Shows its price before the medical questionnaire, so you can compare it without handing over health information
  • The monthly price stays the same as your dose goes up
  • The monthly price includes the medication, clinician visits, shipping and coaching
  • We found no FDA warning letters issued to Healthicare
  • Offers both oral and injectable options, so the format is your choice

Watch-outs

  • Confirm it serves your state before you start the intake
  • Ask which pharmacy fills the prescription before you pay, so you can check its license
  • Its semaglutide and tirzepatide are compounded rather than FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality

Our Verdict

Winner: GOAL.MD

GOAL.MD wins this one, 7.8 to 7.4, above all for starting below a standard dose, with microdose tiers. Healthicare undercuts it by $5 a month, so if the monthly bill is what decides it, Healthicare is the pick. Healthicare fits better if moving between compounded and brand without changing seller is your priority.

Choose GOAL.MD if…

You want starting below a standard dose, with microdose tiers and an opening price near $179 a month.

Choose Healthicare if…

You want moving between compounded and brand without changing seller and an opening price near $174 a month.

Ready to start? GLP-1 providers we have vetted

Telehealth providers, vetted by us, prescribing GLP-1 online.

Vetted by our editors · no insurance required

Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more

7.7

HealthRX

Compounded semaglutide at $133/month

7.3

RNK Health

An oral route if you will not self-inject

9.2

He & She MD

Starting below a standard dose, with microdose tiers

GOAL.MD vs Healthicare: FAQ

Healthicare. It starts at $174 a month; GOAL.MD starts at $179 a month, $5 more per month.
Yes, both sell semaglutide and tirzepatide.
GOAL.MD lists 50 states; Healthicare does not publish where it ships. Confirm your state before paying.
Both include the clinician visit, the medication itself, shipping and coaching.
GOAL.MD has none. Healthicare has none.
No. Neither GOAL.MD nor Healthicare pays us anything.

Or see the full category ranking.

Novo Nordisk A/S owns the Wegovy®, Ozempic® and Rybelsus® marks; Eli Lilly and Company owns Mounjaro® and Zepbound®. Every other product name and mark on this page belongs to whoever owns it. No pharmaceutical manufacturer is affiliated with GLP Watchdog. See trademark disclaimer.